Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year book value per share growth

Percentile
P36
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-60.99%
202411.52%
2023-36.00%
2022-32.20%
2021-41.40%
2020401.63%
2019-71.72%
2018-67.96%
2017-71.36%
2016-64.75%